Department of Pediatrics, Chi Mei Medical Center, 901 Zhonghua Rd., Yongkang District, Tainan City 71004, Taiwan.
Department of Medical Research, Chi Mei Medical Center, 901 Zhonghua Rd., Yongkang District, Tainan City 71004, Taiwan; Department of Information Management, Southern Taiwan University of Science and Technology, 1 Nan-Tai Street, Yongkang District, Tainan City 710301, Taiwan.
Pediatr Neonatol. 2022 Nov;63(6):625-632. doi: 10.1016/j.pedneo.2022.04.011. Epub 2022 Jul 31.
Neonatal hypoglycemia is a common metabolic disorder in newborns, which may present with non-specific symptoms or even be asymptomatic. Current guidelines recommend screening for hypoglycemia in at-risk babies (late preterm, small for gestational age, large for gestational age, and infants of diabetic mothers). Past studies have suggested other potential risk factors, such as maternal obesity, gestational hypertension, cesarean section, etc. In this study, we aim to identify additional prenatal and perinatal maternal/fetal characteristics associated with early asymptomatic hypoglycemia in term and late preterm babies.
We performed a retrospective review on medical charts of all newborns, born between January, 2017 and December, 2020, in the well-baby newborn nursery of a tertiary medical center. We identified newborns who had received blood glucose concentration monitor after birth. Detailed prenatal and perinatal maternal/newborn information were collected for analysis.
In the study period, 841 newborns had received blood glucose screening after birth. After matching by sex and indication for postnatal blood glucose screen (SGA, LGA, and GDM), 148 newborns were included in the "hypoglycemia group" and 296 newborns were included in the "euglycemia group". In the univariate analysis, parity, insulin treatment for gestational diabetes mellitus (GDM), and cesarean section were associated with an increased risk for neonatal hypoglycemia. Factors associated with decreased risk included higher gestational age, longer duration of skin-to-skin contact, neonatal hyperthermia, higher maternal labor pain score, and epidural anesthesia administration. By multivariable analysis, insulin treatment for GDM was identified as an independent factor associated with increased risk for neonatal hypoglycemia.
Our study showed insulin treatment for GDM to be independently associated with neonatal hypoglycemia. Other risk factors noted in the univariate analysis, such as decreased skin-to-skin contact duration, hypothermia, Cesarean section, and preterm delivery, would require further investigation to confirm the findings.
新生儿低血糖是新生儿常见的代谢紊乱,可能表现为非特异性症状甚至无症状。目前的指南建议对高危婴儿(晚期早产儿、小于胎龄儿、大于胎龄儿和糖尿病母亲的婴儿)进行低血糖筛查。过去的研究表明,还有其他潜在的危险因素,如母亲肥胖、妊娠期高血压、剖宫产等。在这项研究中,我们旨在确定与足月和晚期早产儿早期无症状低血糖相关的其他产前和围产期母婴/胎儿特征。
我们对 2017 年 1 月至 2020 年 12 月在一家三级医疗中心的新生儿重症监护室出生的所有新生儿的病历进行了回顾性分析。我们确定了出生后接受血糖浓度监测的新生儿。收集了详细的产前和围产期母婴/新生儿信息进行分析。
在研究期间,有 841 名新生儿在出生后接受了血糖筛查。通过性别和产后血糖筛查的指征(SGA、LGA 和 GDM)匹配后,148 名新生儿纳入“低血糖组”,296 名新生儿纳入“血糖正常组”。单因素分析显示,产次、妊娠期糖尿病胰岛素治疗和剖宫产与新生儿低血糖风险增加相关。与低血糖风险降低相关的因素包括较高的胎龄、较长的皮肤接触时间、新生儿体温过高、较高的产妇分娩疼痛评分和硬膜外麻醉。多因素分析显示,妊娠期糖尿病胰岛素治疗是与新生儿低血糖风险增加相关的独立因素。
我们的研究表明,妊娠期糖尿病胰岛素治疗与新生儿低血糖独立相关。单因素分析中提到的其他危险因素,如皮肤接触时间缩短、体温过低、剖宫产和早产,需要进一步研究以确认这些发现。